DELF Diagnostics Appoints Dr. Amoolya Singh as CTO
DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced the appointment of Dr. Amoolya Singh as Chief...